Yujie Shi
- Pharmaceutical Science top 5%
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 5
- Structural Biology top 10%
- Catalysis top 10%
- Molecular Biology top 10%
- Glycosylation and Glycoproteins Research 6
- RNA Interference and Gene Delivery 4
- Kruppel-like factors research 4
-
- Cancer-related molecular mechanisms research 7
-
- Nanoplatforms for cancer theranostics 6
-
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 4
- Journals
- Cell (1 paper)Journal of Biological Chemistry (1 paper)Angewandte Chemie International Edition (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yujie Shi
60 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Pharmaceutical Science 131
- Biomaterials 226
- Structural Biology 24
- Catalysis 97
- Molecular Biology 799
Countries citing papers authored by Yujie Shi
This map shows the geographic impact of Yujie Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujie Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujie Shi more than expected).
Fields of papers citing papers by Yujie Shi
This network shows the impact of papers produced by Yujie Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujie Shi. The network helps show where Yujie Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yujie Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 14 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 14 | |
| 11 | Nanomedicines Reprogram Synovial Macrophages by Scavenging Nitric Oxide and Silencing CA9 in Progressive Osteoarthritisbreakdown → | 2023 | 70 |
| 12 | 2023 | 20 | |
| 13 | 2022 | 16 | |
| 14 | 2020 | 15 | |
| 15 | 2020 | 71 | |
| 16 | 2019 | 5 | |
| 17 | 2019 | 47 | |
| 18 | 2018 | 45 | |
| 19 | 2017 | 18 | |
| 20 | 2017 | 13 |
About Yujie Shi
Yujie Shi is a scholar working on Structural Biology, Cancer Research and Catalysis, having authored 66 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Nanoplatforms for cancer theranostics (6 papers), Glycosylation and Glycoproteins Research (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Immunotherapy and Immune Responses (5 papers), RNA Interference and Gene Delivery (4 papers), Immune Cell Function and Interaction (4 papers) and Kruppel-like factors research (4 papers). The work is most often cited by research in Pharmaceutical Science (131 citations), Biomaterials (226 citations) and Structural Biology (24 citations). Yujie Shi has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xueqing Wang, Bing He, Samir Mitragotri, Xiangyu Wang, Lu An, Wenbing Dai, Jiancheng Wang, Hua Zhang, Peng Wu and Qiang Zhang. Their work appears in journals such as Cell, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.